Rett syndrome diagnostic odyssey: Limitations of NextGen sequencing

Megan Abbott,Katie Angione,Emily Forbes,Mikayla Stoecker,Margarita Saenz,Jeffrey L. Neul,Eric D. Marsh,Steven A. Skinner,Alan K. Percy,Tim A. Benke
DOI: https://doi.org/10.1002/ajmg.a.63725
2024-05-24
American Journal of Medical Genetics Part A
Abstract:Typical (or classic) Rett syndrome (RTT) is an X‐linked neurodevelopmental disorder characterized by a period of regression, partial or complete loss of purposeful hand movements, and acquired speech, impaired gait, and stereotyped hand movements. In over 95% of typical RTT, a pathogenic variant is found in the methyl‐CPG binding protein 2 gene (MECP2). Here, we describe a young woman with clinically diagnosed typical RTT syndrome who lacked a genetic diagnosis despite 20 years of investigation and multiple rounds of sequencing the MECP2 gene. Recently, additional genetic testing using next‐generation sequencing was completed, which revealed a partial insertion of the BCL11A gene within exon 4 of MECP2, resulting in a small deletion in MECP2, causing likely disruption of MeCP2 function due to a frameshift. This case demonstrates the ever‐changing limitations of genetic testing, as well as the importance of continual pursuit of a diagnosis as technologies improve and are more widely utilized.
genetics & heredity
What problem does this paper attempt to address?